Long-Term Upadacitinib Use Feasible for Adolescents With Atopic Dermatitis

FRIDAY, Oct. 25, 2024-- Long-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks, according to a study published online Oct. 23 in JAMA Dermatology.Amy S. Paller...